Daljeet Kohli of IndiaNivesh has issued a comprehensive report previewing the Q3FY15 results of 18 pharma companies and given clear-cut buy, sell and hold recommendations
Posts tagged Ajanta Pharma
Daljeet Kohli Rakes In Mega Bucks From Favourite Stocks. He Promises More Gains For Us In 2015
Daljeet Kohli has been on a winning streak in 2014. His winning stocks outnumber his losing stocks by a wide margin. He has promised more gains for us in 2015
Shilpa Medicare Gives Mega Gains But Daljeet Kohli Downgrades It To Hold
Shilpa Medicare’s relentless surge has caused Daljeet to sound a note of caution. He has downgraded the price target and advised a hold of the stock
Nesco Delights Daljeet Kohli & Nooresh Merani By Surging 20%
Two ace stock pickers, Daljeet Kohli & Nooresh Merani, took home big bucks today because their stock pick, Nesco, surged 20% to touch an all-time high
Ajanta Pharma Is Upgraded To Hold From Sell: IndiaNivesh
IndiaNivesh has issued an update report stating that the ‘Sell’ rating for Ajanta Pharma has been changed to ‘Hold’. Cogent reasons have been given on what has prompted the change in rating
Should We Buy Or Sell Ajanta Pharma Now?
Ajanta Pharma has been a great wealth-creator stock. It reported robust Q2FY15 results. However, have the valuations run up ahead of fundamentals and should we sell the stock?
Daljeet Kohli Changes Mind On Kajaria Ceramics & Revokes Sell Call
Daljeet Kohli had earlier expressed concern over Kajaria Ceramics’ “aggressive” expansion plans & valuations and had recommended a ‘Sell’. However, its’ robust Q2FY15 results have caused a change of mind & recommendation
Are You Going To Act On Daljeet Kohli’s Advice On Pharma Stocks?
Daljeet Kohli of IndiaNivesh is acknowledged as an authority on the Pharma sector. He understands the sector very well and knows what makes each stock tick. His latest stock recommendations require to be paid attention to by us
Best Pharma Stocks With Buy/ Hold Recommendation
Daljeet Kohli and his team at IndiaNivesh have conducted a comprehensive preview of the Q2FY15E Results of the best pharma stocks and given buy/ hold recommendations
After 85% Gain From Model Portfolio, Daljeet Kohli Thrills With “Top 10” Stock Ideas
Daljeet Kohli continues to thrill the small investor. After a block-buster performance of 85% annualized gains from the Model Portfolio, Daljeet is back with a report on Top 10 stocks. As usual, his logic is simple and convincing
Recent Comments